An inflammatory response with worsening of pleural effusion on treatment with erlotinib in non-small cell lung cancer

By Toh Chee-Keong   Lee Pyng   Chowbay Balram   Goh Jason   Mancer Kent   Tan Puay-Hoon  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 256-258

Informa Healthcare

Access to resources Recommend Favorite

Combination therapy with VEGFR2 and EGFR siRNA enhances the antitumor effect of cisplatin in non-small cell lung cancer xenografts

By                      

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 260-268

Spandidos Publications

Access to resources Recommend Favorite

Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe

By Schiller J.   Tilden D.   Aristides M.   Lees M.   Kielhorn A.   Maniadakis N.   Bhalla S.  

Lung Cancer, Vol. 43, Iss. 1, 2004-01 ,pp. : 101-112

Elsevier

Access to resources Recommend Favorite

Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with nonsquamous non-smallcell lung cancer

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 415-419

Science Publishers

Access to resources Recommend Favorite

Paclitaxel, cisplatin, etoposide combination chemotherapy: a multifractionated bolus dose schedule for non-small cell lung cancer

By Lokich J.   Anderson N.   Bern M.   Coco F.   Gotthardt S.   Oliynyk P.   Dow E.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 659-663

Elsevier

Access to resources Recommend Favorite